Global Intraoperative Neuromonitoring market Size study, by Products and Services (Systems, Accessories, Services), by Source Type (Insourced Monitoring, Outsourced Monitoring), by Application (Spinal Surgery, Neurosurgery, Orthopedic Surgery, ENT Surgery, Vascular Surgery, Other surgeries), by Modality (Motor evoked potentials (MEPs), Somatosensory evoked potentials (SSEPs), Electroencephalography (EEG), Electromyography (EMG), Brainstem auditory evoked potentials (BAEPs), Visual evoked potentials (VEPs)), by End User (Hospitals, Ambulatory Surgical Centers (ASCs)) and Regional Forecasts 2022-2032
Global Intraoperative Neuromonitoring market is valued approximately at USD 5.09 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 6.1% over the forecast period 2024-2032. Intraoperative Neuromonitoring (IONM) is a crucial medical technique that ensures the integrity of the nervous system during surgical procedures by providing real-time feedback on neural pathways. This method employs various advanced technologies, including electrodes and sensors, to monitor neural activity, enhancing surgical precision and patient safety. The increasing geriatric population, along with the prevalence of diseases such as cardiovascular conditions, cancer, and osteoarthritis, significantly propels the demand for IONM. As the aging population grows, the incidence of these diseases is correspondingly soaring, which, in turn, necessitating accurate diagnostic and treatment methods where IONM plays a pivotal role.
Continuous advancements in IONM technologies, such as improved electrodes, real-time data analysis, and advanced signal processing, drive market growth by enhancing the precision and reliability of these monitoring systems. The integration of artificial intelligence and machine learning further augments the capabilities of IONM, making it indispensable in modern surgical practices. However, the high costs of implementation, limited reimbursement policies, and a shortage of skilled professionals pose significant challenges to market growth. Addressing these issues is essential to enhance accessibility and affordability of IONM. The impact of a global recession also presents a dual effect on the market. While economic constraints can limit healthcare budgets and reduce procedural volumes, the emphasis on cost-effective healthcare solutions can drive the adoption of IONM due to its preventive benefits, reducing the need for follow-up treatments. Technological advancements and strategic positioning will be crucial in overcoming these economic challenges.
The key regions considered for the global Intraoperative Neuromonitoring Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in 2023 and is expected to maintain its lead due to its advanced medical infrastructure and high incidence of chronic conditions. Meanwhile, Asia-Pacific is anticipated to exhibit the fastest growth during the forecast period, driven by the adoption of advanced IONM technologies and the prevalence of chronic diseases in the region. Furthermore, significant investments and the presence of key industry players are accelerating the growth of the intraoperative neuromonitoring market in Asia-Pacific.
Major market players included in this report are:
SpecialtyCare
Nihon Kohden Corporation
NuVasive, Inc.
Computational Diagnostics, Inc.
inomed Medizintechnik GmbH
NeuroStyle Pte. Ltd.
Intranerve Neuroscience Holdings, LLC
Accurate Monitoring
Medtronic plc
Natus Medical Incorporated
The detailed segments and sub-segment of the market are explained below:By Products and Services
• Systems
• Accessories
• Services
By Source Type
• Insourced Monitoring
• Outsourced Monitoring
By Application
• Spinal Surgery
• Neurosurgery
• Orthopedic Surgery
• ENT Surgery
• Vascular Surgery
• Other surgeries
By Modality
• Motor evoked potentials (MEPs)
• Somatosensory evoked potentials (SSEPs)
• Electroencephalography (EEG)
• Electromyography (EMG)
• Brainstem auditory evoked potentials (BAEPs)
• Visual evoked potentials (VEPs)
By End User
• Hospitals
• Ambulatory Surgical Centers (ASCs)
By Region:
North America
• U.S.
• Canada
Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
Latin America
• Brazil
• Mexico
• RoLA
Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA
Years considered for the study are as follows:• Historical year – 2022
• Base year – 2023
• Forecast period – 2024 to 2032
Key Takeaways:• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.
Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.